BioCentury
ARTICLE | Company News

Vertex's Agenerase approved in Europe

October 23, 2000 7:00 AM UTC

The European Commission granted marketing approval for VRTX's Agenerase amprenavir protease inhibitor to treat HIV infection/AIDS in combination with other antiretrovirals in protease inhibitor-experi...